Page 82 - ITPS-8-2
P. 82

INNOSC Theranostics and
            Pharmacological Sciences                                          Ketamine and SOD activity in schizophrenia



               chronic intermittent hypoxia, sleep fragmentation, or   characteristics of ketamine effect on locomotion, cognitive
               both during the daylight period. Neurobiol Sleep Circadian   function and central  neuronal activity.  Brain Res Bull.
               Rhythms. 2022;13:100084.                           2006;69(3):338-345.
               doi: 10.1016/j.nbscr.2022.100084                   doi: 10.1016/j.brainresbull.2006.01.010
            25.  Ben-Azu B, Aderibigbe AO, Adeoluwa OA, Iwalewa EO.   33.  Sokoloff P, Leriche L, Diaz J, Louvel J, Pumain R. Direct
               Ethanol extracts of Terminalia ivorensis (Chev A.) stem bark   and indirect interactions of the dopamine D₃ receptor
               attenuates the positive, negative and cognitive symptoms of   with  glutamate  pathways:  Implications  for the  treatment
               psychosis in experimental animal models. Br J Pharm Res.   of schizophrenia.  Naunyn Schmiedebergs  Arch Pharmacol.
               2016;12:1-14.                                      2013;386(2):107-124.
               doi: 10.9734/BJPR/2016/28629                       doi: 10.1007/s00210-012-0797-0
            26.  Ben-Azu B, Adebayo OG, Fokoua AR, Kumanwee L,   34.  Suda Y, Uka T. The NMDA receptor antagonist ketamine
               Uyere EG, Emuakpeje TM. Antipsychotic effect of diosgenin   impairs and delays context-dependent decision making in
               in ketamine-induced murine model of schizophrenia:   the parietal cortex. Commun Biol. 2022;20:5(1):690.
               Involvement of oxidative stress and cholinergic transmission.
               IBRO Neurosci Rep. 2024;16:86-97.                  doi: 10.1038/s42003-022-03626-z
               doi: 10.1016/j.ibneur.2023.12.008               35.  Bošković M, Vovk T, Kores Plesničar B, Grabnar I.
                                                                  Oxidative  stress  in  schizophrenia.  Curr  Neuropharmacol.
            27.  Danduga RCSR, Kola PK. Elevated plus maze for assessment   2011;9(2):301-312.
               of anxiety and memory in rodents. In: Ray SK, editor.
               Neuroprotection. Methods in Molecular Biology. New York:      doi: 10.2174/157015911795596595
               Humana; 2024. p. 2761.                          36.  Rawani NS, Chan AW, Dursun SM, Baker GB. The
               doi: 10.1007/978-1-0716-3662-6_8                   underlying neurobiological mechanisms of psychosis: Focus
                                                                  on neurotransmission dysregulation, neuroinflammation,
            28.  Alex  EA,  Tanko Y,  Muhammed K, et al.  Modulatory  role   oxidative  stress,  and  mitochondrial  dysfunction.
               of lauric acid supplement on lipid peroxidation and some   Antioxidants (Basel) 2024;13(6):709.
               antioxidant enzymes activity in high fat diet, streptozotocin-
               induced type 2 diabetic male wistar rats. J Afr Assoc Physiol      doi: 10.3390/antiox13060709
               Sci. 2019;7(1):23-29.                           37.  Dharmalingam SK, Amirtharaj GJ, Ramachandran A,
            29.  Venâncio C, Félix L, Almeida V, et al. Acute ketamine impairs   Korula  M. Volatile anesthetic preconditioning modulates
               mitochondrial function and promotes superoxide dismutase   oxidative stress and nitric oxide in patients undergoing
               activity in the rat brain. Anesth Analg. 2015;120(2):320-328.  coronary artery bypass grafting.  Ann Card Anaesth.
                                                                  2021;24(3):319-326.
               doi: 10.1213/ANE.0000000000000539
                                                                  doi: 10.4103/aca.ACA_130_20
            30.  Jefferson PG, Alex CM, Ana Cristina CC,  et al. Profiling
               of behavioural effects evoked by ketamine and the role of   38.  Steurer MP, Steurer MA, Baulig W, et al. Late pharmacologic
               5HT  and D  receptors in ketamine-induced locomotor   conditioning with volatile anesthetics after cardiac surgery.
                   2
                         2
               sensitization in mice. Prog Neuropsychopharmacol Biol   Crit Care. 2021;16(5):R191.
               Psychiatry. 2020;97:109775.                        doi: 10.1186/cc11676
               doi: 10.1016/j.pnpbp.2019.109775
                                                               39.  Zhang XY, Zhou DF, Cao LY, Zhang PY, Wu GY, Ying YC. The
            31.  Jonathan A, Naomi EM, Alex LW, Emily MJ, Jessica AS. The   effect of risperidone treatment on superoxide dismutase in
               effects  of  acute  and  repeated  administration  of  ketamine   schizophrenia. J Clin Psychopharmacol. 2003;23(2):128-131.
               on memory, behaviour, and plasma corticosterone levels in   40.  Zhang XY, Zhou DF, Shen YC, et al. Effects of risperidone
               female mice. Neuroscience. 2023;512:99-109.        and haloperidol on superoxide dismutase and nitric oxide in
               doi: 10.1016/j.neuroscience.2022:12.002            schizophrenia. Neuropharmacology. 2012;62(5-6):1928-1934.
            32.  Gabor I, Dirk SF, Johan AD, Gert JTH. Dose-response      doi: 10.1016/j.neuropharm.2011.12.014














             Volume 8 Issue 2 (2025)                        76                               doi: 10.36922/itps.6372
   77   78   79   80   81   82   83   84   85   86   87